𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls

✍ Scribed by Kakkar, Ashish Kumar; Dahiya, Neha

Book ID
122077457
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
256 KB
Volume
94
Category
Article
ISSN
1472-9792

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Review of the Evidence for Using Bedaq
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
✍ Gregory J. Fox, Dick Menzies πŸ“‚ Article πŸ“… 2013 πŸ› Springer Healthcare Communications 🌐 English βš– 600 KB

Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial limitations, in terms of their effectiveness, side-effect profile, and complexity of administration. Bedaquiline is a novel diarylquinoline antibiotic that has recently been investigated as an adjunct to existing ther